DirectSens acquisition news -DirectSens Announces the Acquisition of its LactoSens® Technology by Kerry Group

The acquisition of LactoSens® reflects DirectSens’ success in developing cutting-edge biosensor solutions and represents a move by Kerry Group to complement its offering in lactase enzymes. As an indispensable analytical tool, LactoSens® will work alongside Kerry Group’s ingredient solutions, enabling a more integrated offering for food manufacturers.

Read also - Oriole Networks funding news – London-based Oriole Networks Secures an Additional €20.2 Million Funding

Ronan Moloney, Vice President Enzymes, Kerry Group “We’re excited to bring LactoSens® into Kerry Group’s portfolio to add a new element to our offering, as we fully integrate LactoSens® into our broader solutions for the food and beverage industry.”

Proven track record with global success of LactoSens®

Since its introduction, 8 years ago, LactoSens® has become the industry’s preferred solution for fast, accurate, and cost-effective lactose detection. It is widely used in food and beverage manufacturing, enabling producers to meet stringent regulatory requirements while running their processes efficiently. Its real-time analysis capabilities give manufacturers a competitive edge, solidifying LactoSens® as a market leader.

DirectSens’ Market-Leading Enzyme Engineering and BioSensor technology

Dr. Christoph Sygmund, CEO of DirectSens said, For DirectSens, this acquisition proves the market value of its biosensor technology. “This deal underscores the quality of our biosensor technology and manufacturing capabilities. We will continue to execute on our vision to develop and deliver fast and precise biosensor solutions for key analytes to the global marketplace.”

As the trusted contract manufacturer DirectSens will continue to ensure the high-quality production of LactoSens® upholding the product’s established market reputation. This acquisition reinforces DirectSens’ position as a key innovator in the biosensor industry, demonstrating its ability to not only develop cutting-edge technology but also deliver practical, market-ready products.

A Testament to Long-Term Investment and Austrian Innovation

The acquisition of LactoSens® by Kerry Group marks a defining moment in DirectSens’ 12-year journey from its foundation as a spin-off of BOKU University to becoming a global leader in biosensor technology. DirectSens’ 12 years journey from a spin-off at BOKU University to a global biosensor leader is a testament to the power of long-term vision and sustained support.

Dr. Roman Kittl, COO of DirectSens said, “Our success is a direct result of the unwavering support from our funding partners, who believed in our vision from the very beginning, It’s been a long journey, but the dedication, collaboration, and investment over the years have paid off in a way that truly reflects the strength of Austria’s innovation ecosystem.”

About DirectSens

DirectSens was founded in 2013 in Vienna, Austria, as a biotech company as a spinoff of BOKU University, Vienna). Specializing in the development of biosensors, it provides innovative solutions such as LactoSens®, a rapid lactose detection biosensor. With a commitment to excellence, it continues to expand its product portfolio to meet the evolving demands of the global market.

About Kerry Group

Kerry Group is a world leader in taste and nutrition serving the food, beverage and pharmaceutical markets. With a commitment to innovation, Kerry Group helps its customers create sustainable, delicious, and healthy products for consumers worldwide.